Compare LIVN & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIVN | KD |
|---|---|---|
| Founded | 1987 | 2020 |
| Country | United Kingdom | United States |
| Employees | N/A | 80000 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 2.8B |
| IPO Year | 2015 | 2021 |
| Metric | LIVN | KD |
|---|---|---|
| Price | $64.97 | $13.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $72.43 | $31.00 |
| AVG Volume (30 Days) | 653.4K | ★ 3.2M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 170.95 |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $15,057,000,000.00 |
| Revenue This Year | $9.79 | $3.73 |
| Revenue Next Year | $6.89 | $0.08 |
| P/E Ratio | ★ N/A | $17.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.00 | $10.10 |
| 52 Week High | $71.58 | $43.74 |
| Indicator | LIVN | KD |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 56.63 |
| Support Level | $61.60 | $12.07 |
| Resistance Level | $65.61 | $27.79 |
| Average True Range (ATR) | 2.08 | 0.56 |
| MACD | 0.31 | 0.22 |
| Stochastic Oscillator | 74.25 | 90.54 |
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.